Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hang Ruan

4PUBLICATIONS
6CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radio frequency engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Jun 05, 2026
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

|Apr 23, 2026
PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133<sup>+</sup> cancer stem like cells.

|Jan 11, 2024
Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.

Shenghui Weng, Xinyi Yang, Nannan Yu

|Dec 03, 2022
Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.

Shenghui Weng, Hang Ruan

Pageof 1

Frequent Collaborators

1 joint publications

Shenghui Weng

1 joint publications

Peng-Cheng Wang

1 joint publications

Udhaya Kumar S

1 joint publications

Leng Han

1 joint publications

Xuben Hou

1 joint publications

Zheng Sun

Frequent Collaborators

1 joint publications

Shenghui Weng

1 joint publications

Peng-Cheng Wang

1 joint publications

Udhaya Kumar S

1 joint publications

Leng Han